Dr. Reddy's Laboratories Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	11,204	33,487	24,602	17,277	17,302	24,192
Short-Term Investments	70,223	38,233	33,307	44,050	44,496	20,173
Cash & Short-Term Investments	81,427	71,720	57,909	61,327	61,798	44,365
Cash Growth	22.10%	23.85%	-5.57%	-0.76%	39.29%	28.71%
Accounts Receivable	100,557	101,234	90,420	80,298	72,485	66,764
Inventory	80,473	76,534	71,085	63,552	48,670	50,884
Other Current Assets	36,874	52,305	30,767	42,876	21,302	15,810
Total Current Assets	299,331	301,793	250,181	248,053	204,255	177,823
Net Property, Plant & Equipment	115,549	115,380	96,978	75,997	66,294	61,665
Other Intangible Assets	103,603	105,058	96,803	36,951	30,724	27,011
Goodwill	12,860	14,797	13,139	5,501	5,474	5,473
Long-Term Investments	15,879	14,615	7,204	5,255	5,362	5,986
Other Long-Term Assets	28,083	29,591	29,961	16,881	10,742	19,511
Total Assets	575,305	581,234	494,266	388,638	322,851	297,469
Accounts Payable	37,497	30,379	26,478	26,144	22,684	22,662
Short-Term Debt	57,688	62,935	38,045	12,723	11,190	27,082
Current Portion of Long-Term Debt	2,380	-	-	-	-	-
Current Portion of Leases	-	2,203	857	1,307	1,004	1,017
Other Current Liabilities	59,776	71,957	64,958	55,706	50,843	46,897
Total Current Liabilities	157,341	167,474	130,338	95,880	85,721	97,658
Long-Term Debt	11,884	-	3,800	3,800	-	3,800
Long-Term Leases	-	12,203	4,064	2,190	1,278	1,946
Other Long-Term Liabilities	19,345	19,248	16,790	4,220	2,991	1,941
Total Long-Term Liabilities	31,229	31,451	24,654	10,210	4,269	7,687
Total Liabilities	188,570	198,925	154,992	106,090	89,990	105,345
Common Stock	835	835	834	834	833	832
Treasury Stock	-1,562	-	-	-	-	-
Additional Paid-in Capital	13,140	-	-	-	-	-
Accumulated Other Comprehensive Income	10,444	-	-	-	-	-
Retained Earnings	360,571	378,080	334,662	281,714	232,028	191,292
Total Common Shareholders' Equity	383,428	378,915	335,496	282,548	232,861	192,124
Minority Interest	3,307	3,394	3,778	-	-	-
Shareholders' Equity	386,735	382,309	339,274	282,548	232,861	192,124
Total Liabilities & Equity	575,305	581,234	494,266	388,638	322,851	297,469
Total Debt	71,952	77,341	46,766	20,020	13,472	33,845
Net Cash (Debt)	9,475	-5,621	11,143	41,307	48,326	10,520
Net Cash Growth	-47.49%	-	-73.02%	-14.52%	359.37%	184.32%
Net Cash Per Share	7.74	-6.75	13.36	49.56	58.09	12.65
Book Value	383,428	378,915	335,496	282,548	232,861	192,124
Book Value Per Share	313.11	454.70	402.19	338.97	279.90	231.00
Tangible Book Value	266,965	259,060	225,554	240,096	196,663	159,640
Tangible Book Value Per Share	218.01	310.87	270.39	288.05	236.39	191.95

SEC Filings: 10-K · 10-Q